*Disclaimer : This is as of previous day’s closing price.
Below is a quick look at 5 technical indicators for CRISPR Therapeutics AG. More studies are available on the Technical Chart.
|Closing Price above/below 50 Day Moving Average||Bullish|
|Closing Price above/below 200 Day Moving Average||Bullish|
|50 Day Moving Average above/below 200 Day Moving Average||Bullish|
|RSI Reading Level (<30 or >70)||Oversold|
|MACD Compared to 9D EMA Signal Line||Bullish|
View these and more technical studies for CRISPR Therapeutics AG
Share Price Performance Relative to Peers
CRSP-US has traded publicly for less than a year.
CRSP-US‘s shares have traded publicly for less than a year. Over the last one month, however, the company’s share price has performed in line with its peers with a return of 3.79% .
Screen for companies using relative share price performance
CRISPR Therapeutics AG has an earnings score of 43.08 and has a relative valuation of OVERVALUED.
Stocks with High Earnings Momentum are a preferred option for momentum plays. If they are undervalued, it can be a further advantage and may indicate sustained momentum.
Quadrant label definitions. Hover to know more
Screen for companies using Earnings Momentum Score